BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 10, 2021
View Archived Issues
ROR1 TriKE candidate shows promise in preclinical models of prostate cancer
Read More
SLP76 deficiency leads to severe combined immunodeficiency in humans
Read More
FDA clears initiation of phase I study of TTAX-03 for facet joint pain in osteoarthritis
Read More
Preliminary topline data reported from phase IIb ALTISSIMO study of GB-102
Read More
JCR discontinues development of JR-031EB for epidermolysis bullosa
Read More
Sorrento and Mount Sinai to develop antibody combinations against SARS-CoV-2
Read More
Dovitinib demonstrates promising antitumor activity in preclinical model of osteosarcoma
Read More
First patient dosed in phase IIa study of MET-642 for the treatment of NASH
Read More
Surface Oncology and Merck & Co. collaborate on immune-oncology study of SRF-388
Read More
Pirtobrutinib demonstrates safety and efficacy in multiple B-cell malignancies
Read More
Hitgen discloses new IL1-7RA antagonists
Read More
Wigen Biomedicine Technology divulges KRAS mutant inhibitors
Read More
E.U. researchers patent viral compounds for synucleinopathies
Read More
Inorbit Therapeutics synthesizes FFAR1 agonists
Read More
Artios Pharma describes new POLQ inhibitors
Read More
FDA clears IND for phase II trial of Melior's tolimidone for COVID-19
Read More
At CROI, two-way street between HIV and SARS-CoV-2
Read More
Phase III trial results reported for blinatumomab in children with high-risk first-relapse B-ALL
Read More
BARDA to fund proof-of-concept studies of ibudilast for chlorine gas-induced lung damage
Read More
Initial phase I data on tri-specific COVID-19 antiviral treatment ensovibep in healthy volunteers
Read More
VBI begins phase I/II study of COVID-19 vaccine candidate VBI-2902
Read More
PI3K inhibitor umbralisib shows clinical activity in patients with indolent non-Hodgkin's lymphoma
Read More
Dosing begins in first-in-human study of CAN-106 for complement dysregulation diseases
Read More
Affimed continues REDIRECT trial of AFM-13 in PTCL after interim futility analysis
Read More
